Insider Trading activities at Amag Pharmaceuticals, Inc. (AVM)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amag Pharmaceuticals, Inc. (AVM) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amag Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 792977.

Total stock buying since 2015: $9,032,924.
Total stock sales since 2015: $130,188,818.
Total stock option exercises since 2015: $1,360,848.


11 insiders reported insider trading activities at Amag Pharmaceuticals, Inc. (AVM):
Insider trading activities of Krop Julie
Insider trading activities of Heiden William K
Insider trading activities of Bolgiano Elizabeth Scott
Insider trading activities of Holmes Scott A
Insider trading activities of Camber Capital Management Lp
Insider trading activities of Fallon John A.
Insider trading activities of Boyd Steven
Insider trading activities of Thomas Frank E
Insider trading activities of Wilson Kenneth H
Insider trading activities of Vittiglio Joseph
Insider trading activities of Gross Phillip

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Amag Pharmaceuticals, Inc. (AVM).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2020 180,466 $1,173,453 4,402,466 $59,662,946 0 $0
2019 1,208,016 $7,758,695 1,425 $19,964 0 $0
2018 0 $0 25,770 $641,016 0 $0
2017 0 $0 8,079 $165,931 0 $0
2016 0 $0 4,938 $122,462 0 $0
2015 3,230 $100,776 1,415,359 $69,576,499 101,234 $1,360,848

Table 2. Monthly summary of insider trading at Amag Pharmaceuticals, Inc. (AVM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2020-10 0 $0 4,390,000 $59,585,470 0 $0
2020-03 24,000 $116,880 0 $0 0 $0
2020-02 36,000 $298,439 0 $0 0 $0
2020-01 120,466 $758,134 12,466 $77,476 0 $0
2019-08 685,000 $4,480,370 0 $0 0 $0
2019-06 498,016 $3,017,575 0 $0 0 $0
2019-05 25,000 $260,750 0 $0 0 $0
2019-03 0 $0 1,425 $19,964 0 $0
2018-08 0 $0 5,000 $125,000 0 $0
2018-06 0 $0 20,000 $500,000 0 $0
2018-03 0 $0 770 $16,016 0 $0
2017-08 0 $0 1,250 $20,937 0 $0
2017-07 0 $0 4,938 $98,760 0 $0
2017-05 0 $0 1,891 $46,234 0 $0
2016-10 0 $0 4,938 $122,462 0 $0
2015-11 3,230 $100,776 0 $0 0 $0
2015-10 0 $0 2,000 $79,380 0 $0
2015-09 0 $0 2,000 $122,380 0 $0
2015-08 0 $0 17,000 $1,131,809 15,000 $223,650
2015-07 0 $0 22,000 $1,638,820 20,000 $259,800
2015-06 0 $0 122,359 $8,484,931 66,234 $877,398
2015-01 0 $0 1,250,000 $58,119,179 0 $0

Table 3. Detailed insider trading at Amag Pharmaceuticals, Inc. (AVM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-10-01 Camber Capital Management Lp Sale 4,390,000 13.57 59,585,470
2020-03-16 Boyd Steven Buy 24,000 4.87 116,880
2020-02-25 Boyd Steven Buy 36,000 8.29 298,439
2020-01-27 Boyd Steven Buy 16,000 6.28 100,480
2020-01-24 Boyd Steven Buy 74,000 6.43 476,042
2020-01-10 Boyd Steven Buy 18,000 5.82 104,760
2020-01-09 Boyd Steven Buy 12,466 6.17 76,852
2020-01-09 Boyd Steven Sale 12,466 6.21 77,476
2019-08-09 Camber Capital Management Lp Buy 30,000 9.06 271,770
2019-08-07 Boyd Steven Buy 300,000 4.92 1,475,100
2019-08-07 Camber Capital Management Lp Buy 355,000 7.70 2,733,500
2019-06-27 Boyd Steven Buy 64,000 6.33 405,120
2019-06-26 Boyd Steven Buy 120,000 4.57 547,800
2019-06-25 Boyd Steven Buy 314,016 6.58 2,064,655
2019-05-28 Krop Julie (Chief Medical Officer) Buy 10,000 9.91 99,100
2019-05-09 Bolgiano Elizabeth Scott (Chief Human Resources Officer) Buy 5,000 10.93 54,650
2019-05-09 Heiden William K (President & CEO) Buy 10,000 10.70 107,000
2019-03-07 Vittiglio Joseph (EVP, General Counsel) Sale 1,425 14.01 19,964
2018-08-07 Heiden William K (President & CEO) Sale 5,000 25.00 125,000
2018-06-04 Heiden William K (President & CEO) Sale 20,000 25.00 500,000
2018-03-06 Vittiglio Joseph (EVP, General Counsel) Sale 770 20.80 16,016
2017-08-29 Vittiglio Joseph (SVP, General Counsel) Sale 1,250 16.75 20,937
2017-07-13 Krop Julie (SVP Clinical & Regulatory, CMO) Sale 4,938 20.00 98,760
2017-05-01 Krop Julie (SVP Clinical & Regulatory, CMO) Sale 1,891 24.45 46,234
2016-10-20 Krop Julie (SVP Clinical & Regulatory, CMO) Sale 4,938 24.80 122,462
2015-11-10 Fallon John A. Buy 3,230 31.20 100,776
2015-10-01 Heiden William K (CEO) Sale 2,000 39.69 79,380
2015-09-01 Heiden William K (CEO) Sale 2,000 61.19 122,380
2015-08-05 Thomas Frank E (President & COO) Sale 15,000 66.85 1,002,749
2015-08-05 Thomas Frank E (President & COO) Option Ex 15,000 14.91 223,650
2015-08-03 Heiden William K (CEO) Sale 2,000 64.53 129,060
2015-07-15 Heiden William K (CEO) Sale 20,000 75.00 1,500,000
2015-07-15 Heiden William K (CEO) Option Ex 20,000 12.99 259,800
2015-07-01 Heiden William K (CEO) Sale 2,000 69.41 138,820
2015-06-15 Holmes Scott A (SVP, Finance and Treasurer) Sale 7,580 66.63 505,055
2015-06-15 Holmes Scott A (SVP, Finance and Treasurer) Option Ex 6,234 15.72 97,998
2015-06-05 Heiden William K (CEO) Sale 66,875 69.80 4,668,142
2015-06-05 Heiden William K (CEO) Option Ex 60,000 12.99 779,400
2015-06-04 Thomas Frank E (President & COO) Sale 20,000 69.52 1,390,300
2015-06-03 Wilson Kenneth H (SVP, Sales and Marketing) Sale 5,388 68.77 370,532
2015-06-03 Holmes Scott A (SVP, Finance and Treasurer) Sale 22,516 68.88 1,550,902
2015-01-09 Gross Phillip Sale 17,493 43.48 760,595
2015-01-08 Gross Phillip Sale 142,507 46.06 6,564,584
2015-01-07 Gross Phillip Sale 1,090,000 46.60 50,794,000

Insider trading activities including stock purchases, stock sales, and option exercises of AVM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amag Pharmaceuticals, Inc. (symbol AVM, CIK number 792977) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.